Blood thinners after leg artery surgery to prevent clots
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial compares two blood-thinning strategies after leg artery surgery or angioplasty to prevent dangerous blood clots. Participants will receive either rivaroxaban plus aspirin or aspirin alone, and researchers will monitor for clots over 30 days.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (any age, any gender).
- You have critical limb ischemia (severe leg artery blockage) and are scheduled for a procedure to open or bypass the blocked arteries.
- You have not had a blood clot during your current hospital stay.
- You do not have any condition that would make taking rivaroxaban unsafe (like allergies or bleeding risk).
- You are able to return for a checkup 30 days after your procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different blood thinner medications to see which works best at preventing serious problems like heart attack or stroke after a leg artery procedure. It is for people with peripheral artery disease (PAD) who had a balloon or stent placed in their leg arteries.
This study tests a personalized approach to prevent blood clots in patients who have had surgery to repair blocked arteries in their legs. Researchers want to find the best blood-thinning medication for each individual to reduce serious complications while keeping you safe.
This trial compares two blood thinners, Rivaroxaban (a pill) and Enoxaparin (a shot), to see which works better at preventing dangerous blood clots in the legs after emergency abdominal surgery. It may help you if you need to stay in bed for more than a day after your operation.
This trial tests a blood thinner called rivaroxaban (Xarelto) given right after heart valve surgery with a tissue valve. It aims to see if it can prevent blood clots or strokes safely in the early recovery period.
This trial tests if a new blood-thinning drug (factor XI inhibitor) can prevent serious heart and leg problems in people who recently had a leg artery procedure. It compares the new drug to standard care for up to 3 years.
This trial tests if a blood thinner called Rivaroxaban can treat a blood clot that forms in the wrist artery after a heart catheterization. If you have this clot, taking Rivaroxaban may help reopen the artery and improve blood flow.
Hear when a new Peripheral Arterial Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.